PubMed Health⌕ Search

Biomedical subjects

B Jelatancev

Publications and source records attributed to B Jelatancev.

6 recordsLinked to original sources

Low doses of heparin and heparin dihydergot in postoperative thromboprophylaxis in gynaecological patients.

A prospective study of postoperative thromboembolic prophylaxis involving 500 gynaecological patients was performed to compare the effectiveness and safety of low doses of heparin (LDH) and heparin-dihydergot (HDHE). In the LDH group 255 patients (51%) aged 26-84 were included, in the HDHE group there were 245 patients (49%) aged 34-86. Both groups were well matched with respect to risk factors, duration of surgery, type of operation, volume of blood transfused and duration of prophylaxis. Thromboembolism was detected in 48 patients (9.6%): 26 patients (10.2%) in the LDH group and 22 patients (9%) in the HDHE group. In the LDH group isotopic deep vein thrombosis (DVT) was found in 23 patients (9%), five of them had pulmonary embolism (PE), detected by lung perfusion scanning without clinical signs of PE, three patients developed clinical PE without detected DVT. In the HDHE group, 22 patients (9%) had isotopic DVT and five of them had PE detected by lung perfusion scanning. In the incidence of TE there was no statistically significant difference between the two groups (p > 0.1). Within two months after surgery late clinically manifest TE confirmed by isotopic venography developed in five patients (1.9%) in the LDH group and in one patient (0.4%) in the HDHE group. Wound haematomas appeared in 8 patients (3.1%) in the LDH group and in 9 patients (3.7%) in the HDHE group. There were no ischemic complications (ergotism) in the HDHE group. The HDHE prophylaxis proved no more effective and was ten times more expensive than the usual prevention with LDH.

Adult↗

Prevention of postoperative thromboembolism in gynaecological malignancy.

A prospective randomized clinical trial compared the efficacy of low doses of heparin (LDH) and heparin plus dihydroergotamine mesylate (HDHE) in the prevention of thromboembolism in gynaecological patients with malignancy undergoing major surgery. One hundred and fifty-five patients, with a mean age 54.5 years were allocated to receive 5,000 IU unfractionated heparin or 5,000 IU unfractionated heparin +0.5 mg dihydroergotamine mesylate twice daily. Treatment was begun 2 hours preoperatively and continued until discharge (12 +/- 7 days). The incidence of thromboembolism determined by radiolabelled fibrinogen and lung perfusion scanning was 21.3% in LDH group and 22.7% in HDHE group. There were no statistically significant differences between the two groups (p > 0.1). The observed haemorrhagic rate was 1.9% in both groups. HDHE prevention was more expensive but without significant advantage over LDH. During two months after surgery 4 patients (5%) in the LDH group and 1 patient (1.8%) in the HDHE group developed deep vein thrombosis.

Adult↗

[Polyagglutinability in erythrocytes].

A case of erythrocyte polyagglutinability is presented which developed in a patient who underwent surgery in the course of infection with Clostridium perfringens. When blood transfusion became necessary it was decided that the patient be transfused with concentrated and washed erythrocytes. The transfusion was well tolerated. With the curing of the infection the polyagglutinability also disappeared.

Adult↗

[Sensitization to Cw antigen].

This paper describes a patient who, after being subjected to repeated blood Transfusions, has developed antibodies to Antigen Cw.

Female↗

[Prevention of thromboembolic disease in gynecologic surgery].

The authors present the results of their blind prospective comparative study of the postoperative thromboembolic protection of 490 gynecologic patients. Among them 250 (51%) were protected by a low dose heparin (LDH) subcutaneously in 12-hour intervals, 240 (49%) received heparindihydergot (HDHE). Thromboembolisms diagnosed by the 125J fibrinogen uptake test appeared in 26 (10.4%) patients protected by LDH and 23 (9.6%) by HDHE. The most frequent risk factors in patients with thromboembolisms were malignant diseases, obesity, varicose veins, hypertension and a history of deep vein thrombosis or pulmonary embolism. Haemorrhages appeared in 7 (2.8%) patients protected by LDH and 8 (3.3%) by HDHE.

Adult↗